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Abstract
Here we report the results of an investigation into the possibility that one mechanism responsible for the establishment of persistent human immunodeficiency virus infection is an early regulatory T (Treg) cell response that blunts virus-specific responses. Using the simian immunodeficiency virus (SIV)–infected rhesus macaque model, we show
that, indeed, viral replication and immune activation in lymphatic tissue drive a premature immunosuppressive response, with dramatic increases in the frequencies of CD4+CD25+FOXP3+ Treg cells, transforming growth factor–β1+
cells, interleukin–10+ cells, and indoleamine 2,3-dioxygenase+CD3+ cells.When we compared SIV infection with rhesus cytomegalovirus (RhCMV) infection, we found that the frequency of Treg cells paralleled the magnitude of immune
activation during both infections but that the magnitude of immune activation and of the Treg cell response were lower
and peaked much later during RhCMV infection. Importantly, the frequency of Treg cells inversely correlated with the
magnitude of the SIV-specific cytotoxic T lymphocyte response. We conclude that an early Treg cell response during
acute SIV infection may contribute to viral persistence by prematurely limiting the antiviral immune response before infection is cleared.

G

enerally, viral infections activate the immune system,
which generates large numbers of immune cells, cytokines, and other effectors that are needed to terminate the
infection by eradicating infected cells and virus [1]. This
initial expansion stage is followed by a contraction stage,
during which, it is currently thought, regulatory T (Treg)
cells play a prominent role in maintaining the delicate balance between an immune response that is sufficiently robust to clear the infection and the immunopathological
consequences of sustained immune activation and inflammation [2, 3].

Similarly, during the early stages of HIV and simian
immunodeficiency virus (SIV) infection, viral replication
in lymphatic tissue activates the immune system, and viral levels decrease in concert with increasing numbers
of virus-specific cytotoxic T lymphocytes (CTLs) [4, 5].
However, HIV and SIV infections are typically persistent,
with viral replication continuing because of the incomplete clearance of productively infected cells. Among the
many mechanisms that contribute to the inability of CTLs
to eliminate all of the productively infected cells, there is
increasing evidence (particularly from the SIV-infected
703
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rhesus macaque [RM] model) indicating that the CTL response is too little, too late [6, 7]. Because several studies have shown that the magnitude of effector T cell immune responses to acute viral infections can be limited by
Treg cells [8–10], and because Treg cells may enable some
pathogens to establish chronic infection by blunting the
immune response, we hypothesized that an immunosuppressive Treg cell response might be one mechanism that
delays and limits the CTL response during acute lentiviral
infection, resulting in virus-specific responses of insufficient magnitude to clear these infections. In this hypothesis, the immunosuppressive Treg cell response is untimely
or premature in that it kicks in to regulate the massive immune activation and inflammation in lymphatic tissue so
quickly that it dampens the CTL response before infected
cells have been completely eliminated. We tested this hypothesis using the SIV-infected RM model, in which we
could examine, during the acute stage of infection, the
relationship between viral replication and immune defense and immunoregulatory responses. We show that, in
lymphatic tissue, Treg cells and immunosuppressive mediators are induced so early in response to immune activation that SIV-specific CTL responses are constrained
at just the time when they are most needed to clear the
infection.
Materials and Methods
Animals and experimental SIV and rhesus cytomegalovirus
(RhCMV) infections. To characterize the early Treg cell response in lymphatic tissue, we studied tissues from 3 different experiments in SIV-infected RMs and from a separate study of primary RhCMV infection. In the first study,
lymph node (LN) tissues were obtained at necropsy from
4 adult female Indian RMs 1–12 days after atraumatic intravaginal (ivag) infection, as described elsewhere [11]. In
the second study, LN tissues were obtained at necropsy
from 5 adult female RMs 2 h–28 days after ivag inoculation
of TCID50 of SIVmac251 2 × 105 or SIVmac239 [12]. In the third
study, which was longitudinal, LN biopsy samples were
obtained from 4 adult female RMs before and 7 and 28
days after intravenous (iv) infusion of 1 MID50 of SIVmac239.
In the fourth study, 4 CMV-negative juvenile RMs were
subcutaneously inoculated with 1 × 106 pfu of CMV strain
68.1 at 2 sites. LN biopsy samples were obtained 21 days
before and 7, 14 (2 RMs), 28 (2 RMs), and 70 days after infection. Tissues were snap-frozen in liquid nitrogen and
embedded in OTC for long-term storage. All animal studies were approved by the appropriate institutional review
board.
Immunohistochemical staining, in situ hybridization,
quantitative image analysis, and tetramer staining. Single immunohistochemical staining, in situ hybridization,
and quantitative image analysis were performed as described elsewhere [11, 13]. Antibodies used were rabbit and
goat anti–transforming growth factor (TGF)–β1, goat antiFOXP3, mouse and rabbit anti–interleukin (IL)–10 (all from
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Santa Cruz Biotech), rabbit anti-FOXP3 (gift from A. Y.
Rudensky, M. A. Gavin, and P. deRoos, Howard Hughes
Medical Institute, University of Washington), rabbit antiCD3 (DakoCytomation), mouse anti– indoleamine 2,3-dioxygenase (IDO; Chemicon International), mouse anti-CD4
(Novocastra Laboratories), and mouse anti-CD25 (NeoMarkers). Anti-FOXP3 (Santa Cruz Biotech) specificity was
determined by incubating the antibody with the FOXP3
peptide used as the immunogen at a peptide:antibody ratio
of 20:1 before incubation with tissue sections. Although the
peptide-blocking treatment did not completely abrogate
FOXP3 staining in all tissue samples, it did dramatically reduce the detection of FOXP3 by use of antibody (data not
shown). Dual-label immunofluorescence confocal microscopy was performed as described elsewhere [13]. Tetramer
analysis on CTLs from lymphatic tissue was performed as
described elsewhere [14].
Statistical methods. For quantitative image-analysis
data, the mean for each RM was derived from at least 18
randomly acquired high-power images. The graphs show
either individual means (for groups with n = 1) or group
means (derived by averaging all individual RM means ±
SEs). To assess increases in the frequency of TGF-β1+ and
FOXP3+ cells during infection, we fit linear models for
each protein, pooling all of the data from the RMs into 1
model. Linearity was assessed graphically for those RMs
with multiple measurements and was also more formally
assessed by incorporating a quadratic termin the models; both of these strategies suggested that the linearity of
change over time was reasonable. In a linear model that
allowed for correlation within measurements from the
same RM, model parameters were estimated using maximum likelihood (using S-plus [version 3.1, release 1],
a statistical program from Math-Soft). To test whether
the magnitude of the responses was increasing, we conducted a hypothesis test on the slope parameter in the linear model. This test indicated that the changes observed
for both TGF-β1+ cells and FOXP3+ cells were statistically significant (P < .0001, for both). To test for an association between the frequency of Treg cells and the percentage of SL8 tetramer+CD8+ T cells, a random-effects model
was used (using restricted maximum likelihood, as implemented in the varcomp function in S-plus). This model allows for testing an association when multiple measurements are taken from individual subjects and one wants
to combine these measurements. This model was also
used to investigate the effect of LN location on the association; however, because no such effect was found, the
data were aggregated.
Results
In recent experiments investigating the CTL response to
SIV after ivag infection, we found that the response to immunodominant epitopes in SIV was too late in the sense
that it was not detectable until several days after the peak
of virus replication in lymphatic tissue [7]. Moreover, the
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Figure 1. Dramatic increase in transforming growth factor (TGF)–β1 expression in the paracortical T cell zones of lymph nodes
during acute simian immunodeficiency virus (SIV) infection of rhesus macaques (RMs). A, Images showing a significant increase
in the frequency of TGF-β1+ cells (upper panels) in the paracortical T cell zones of secondary lymphatic tissue shortly after both intravenous (iv) and intravaginal (ivag) SIV infection (TGF-β1+ cells are indicated by brown staining; original magnification, ×400).
Productively infected cells (lower panels) were detected by in situ hybridization within 7 days of iv infection, and the level peaked
at 28 days after iv infection, whereas the level of productively infected cells peaked at 12 days and remained high until 21 days after ivag infection (original magnification, ×100). B, Enumeration of the frequency of TGF-β1+ cells. TGF-β1+ cells were enumerated in at least 18 randomly acquired high-power images for each RM, and the graphs show either individual means (for groups
with n = 1) or group means (derived by averaging all individual RM means ±SEs); the no. of RMs at each time point is shown in
parentheses. To determine whether the increase in TGF-β1 expression was statistically significant over time, the data were fit into
a model that incorporated data from all RMs and time points, as outlined in Materials and Methods. This model indicated that the
change observed for TGF-β1 expression was statistically significant (P < .0001).
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Figure 2. Dramatic increase in FOXP3+ regulatory T (Treg) cells in the paracortical T cell zones of lymph nodes during acute simian immunodeficiency virus (SIV) infection of rhesus macaques (RMs). A, Expression of FOXP3 by CD4+CD25+ Treg cells, phenotypically identifying them as natural Treg cells. The majority of FOXP3+ cells were transforming growth factor–β1 and interleukin–10
positive (original magnification, ×640). B, Rapid increase in the frequency of FOXP3+ Treg cells (brown staining) in the paracortical
T cell zones of secondary lymphatic tissue after both intravenous and intravaginal SIV infection (original magnification, ×400). C,
Frequency of FOXP3+ Treg cells. The frequency of FOXP3+ Treg cells was determined and plotted as described in figure 1. To determine whether the increase in FOXP3 expression was statistically significant over time, the data were fit into a model that incorporated data from all RMs and time points, as outlined in Materials and Methods. This model indicated that the change observed
for FOXP3 expression was statistically significant (P < .0001).

response was too little in the sense that the number of SIVspecific CTLs decreased from peak levels even while productively infected cells remained in lymphatic tissue.
To investigate the possibility that one reason for the failure to clear infection was an early immunosuppressive response that prematurely limited the immune response
before the infection had been cleared, we examined lymphatic tissue obtained during acute SIV infection, to evaluate the relationship that might exist between the timing
and magnitude of immunosuppressive responses and viral
replication.
Induction of TGF-β1+ cells during acute SIV infection.
We began by assaying TGF-β1, a potent immunosuppressive soluble mediator and major effector molecule used by
CD4+CD25+ Treg cells. Analyzing the period from the onset of viral replication in lymphatic tissue (~7 days after
infection), through the peak (10–14 days) and subsequent

decrease of replication, and to the time of persistent infection (28 days), during which sustained levels of replication
are characteristic [12], we quantified TGF-β1 expression in
pooled LN biopsy samples from separate studies of acute
infection after inoculation of SIV by iv and ivag routes.
In LN samples obtained sequentially from the same RMs
that had been iv infected, there were few TGF-β1+ cells before infection, but, by 7 days after infection, the frequencies of TGF-β1+ cells in the paracortical T cell zones had increased >4-fold, and, by 28 days after infection, they had
increased >11-fold (figure 1A and 1B). There was a similar rapid increase in LN samples obtained at necropsy from
RMs 12, 14, and 21 days after ivag infection—the frequencies of TGF-β1+ cells were >10- fold higher in infected RMs
than in uninfected control RMs (figure 1A and 1B).
The rapidity of the TGF-β1 response was consistent
with the hypothesis that the early peak of viral replication

Premature Induction

of an

I m m u n o s u pp r e s s i v e R e g u l a t o r y T C e l l R e s p o n s e

707

Table 1. In vivo phenotype of regulatory T (Treg) cells expressed in lymph nodes from simian immunodeficiency virus–
infected rhesus macaques 14 days after infection.
Cell type
Natural Treg cells (FOXP3+)
Th3 cells (TGF-β1+)
Type 1 Treg cells

(IL-10+)

FOXP3+

TGF-β1+

IL-10+

IDO+

…

67.5 ± 13.8 (36.1–93.9)

58.3 ± 7.5 (46.8–70.6)

83.0 ± 11.9 (62.2–100)

76.2 ± 16.7 (53.2–97.2)

…

ND

ND

67.9 ± 9.2 (51.5–89.4)

ND

…

ND

Data are the mean ± SD (range) percentage of cells in the left column expressing the antigen listed at top. Eighteen randomly
acquired high-power confocal images were obtained and processed in Photoshop, and quantitative image analysis was performed to determine the colocalization of the 2 different antigens of interest. IDO, indoleamine 2,3-dioxygenase; IL, interleukin;
ND, not determined; TGF, transforming growth factor.

was driving this immunoregulatory response. Indeed, we
found that the peak of the TGF-β1 response occurred soon
after the peak of virus replication, from days 10 to 14. More
importantly, the frequency of TGF-β1+ cells remained high
when there were still significant numbers of productively
infected cells in lymphatic tissue (figure 1A, lower panels),
a finding that is consistent with the hypothesis that this immunosuppressive response is premature with respect to
the host defense’s attempt to eradicate the infection.
Induction of CD4+CD25+FOXP3+ Treg cells during acute
SIV infection. We next established that the TGF-β1 response is just one manifestation of an early general immunosuppressive response composed of Treg cells and potent immunosuppressive mediators. We quantified the Treg
cell response by staining tissue sections for the transcription factor that controls the generation of natural Treg cells,
FOXP3 [15, 16], and for CD4 and CD25. The majority of the
FOXP3+ cells (mean ± SD, 93.4% ± 4.2%) that accumulated
rapidly in the paracortical T cell zones of secondary lymphatic tissue shortly after SIV infection were CD4+CD25+
Treg cells (figure 2A). In addition, we found that most of the
TGF-β1+ cells (mean ± SD, 76.2% ± 6.7%) also coexpressed
FOXP3 and were CD4+CD25+ Treg cells (figure 2A and table
1), with the rest presumably being Th3 cells. Importantly,
the increased frequency of FOXP3+ Treg cells in secondary
lymphatic tissue (figure 2B and 2C) was approximately
equal to the increased frequency of TGF-β1+ cells. Because
human Treg cells are highly susceptible to HIV infection in
vitro [17], we reasoned that the dramatic increase in the frequency of Treg cells reported here could provide a highly
susceptible population of target cells for further SIV propagation, and we investigated the possibility that the increase
in the frequency of Treg cells was limited by productive infection. Surprisingly, at the peak of viral replication (10–14
days after infection), we found that, on average, only 13%
of FOXP3+ Treg cells in secondary lymphatic tissue were infected (SIV RNA+; data not shown), indicating that, in vivo,
productive infection of Treg cells does not greatly contribute to limiting the expansion of this population.
Induction of IL-10+ and IDO+CD3+ Treg cells during acute SIV infection. Because IL-10 has been shown to
be a potent immunosuppressive mediator in a variety of

settings and can be expressed by both natural Treg cells and
type 1 Treg cells, we investigated changes in the frequency
of IL-10+ cells (figure 3A). We found that the frequency of
IL-10+ cells increased as early as 7 days after infection with
a dramatic increase by 28 days, which was similar in magnitude and timing to the increased frequency of TGF-β1+
cells and FOXP3+ Treg cells. Moreover, we also found increased frequencies of cells expressing IDO (figure 3B), an
interferon (IFN)–γ inducible enzyme that generates such
highly immunosuppressive byproducts as n-formylkynurenine by oxidative degradation of tryptophan.We suspected that tolerogenic dendritic cells (DCs) might be the
source of the IDO, on the basis of the study by Munn et
al. demonstrating the existence of a subset of monocyte-derived DCs that use this enzyme to suppress T cell proliferation in vitro [18]. However, we found that, during acute
SIV infection, most of the IDO+ cells were CD3+ T cells (figure 3B) and that most were, in fact, FOXP3+ Treg cells (mean
± SD, 83.1% ± 10.6%). Moreover, a detailed analysis of the
phenotype of Treg cells at peak induction revealed a highly
heterogeneous Treg cell population that included natural
Treg cells (FOXP3+), Th3 cells (FOXP3–TGF-β+), and type 1
Treg cells (FOXP3–IL10+) (table 1). On the basis of the strong
correlation between the frequency of CD4+FOXP3+ cells
and the frequencies of TGF-β1+, IL-10+, and IDO+CD3+
cells, we conclude that a heterogeneous population of Treg
cells expressing several powerful immunosuppressive mediators is induced during acute SIV infection.
Kinetics of induction of Treg cells parallel kinetics of
immune activation but differ during SIV and RhCMV infection. We hypothesized that the immune activation that
accompanied viral replication in SIV-infected LNs was
driving the early induction of the immunosuppressive response, and we tested this hypothesis in 2 ways: (1) by
characterizing the relationship between the kinetics of the
induction of Treg cells and the kinetics of immune activation during SIV infection and (2) by comparing this relationship with that for infection with another virus, RhCMV, during which immune activation occurs later and in
response to antigenic stimulation only, rather than to the
combined effect of antigenic stimulation and viral infection in lymphatic tissue, as is the case for SIV. Consistent
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Figure 3. Rapid induction of immunosuppressive interleukin (IL)–10 and indoleamine 2,3-dioxygenase (IDO) in the paracortical
T cell zones of lymph nodes during acute simian immunodeficiency virus (SIV) infection of rhesus macaques. The frequencies of
both IL-10+ cells (A) and IDO+ cells (B; left panels) increased shortly after both intravenous and intravaginal SIV infection. Most
IDO+ cells were CD3+ T cells (B; right panel), not dendritic cells (as determined on the basis of phenotypic analysis of dual-stained
tissue at peak expression of IDO) (original magnification, ×400).

with this hypothesis, we found that the kinetics of the induction of FOXP3+ Treg cells paralleled the kinetics of immune activation (Ki67+ cells) in the paracortical T cell
zones of secondary lymphatic tissue from 4 RMs after iv
SIV infection (figure 4A). In addition, we found that, although there was a positive correlation between the frequency of Treg cells and that of SIV RNA+ cells (r = 0.5969),
there was a much stronger relationship between the frequency of Treg cells and the magnitude of the immune activation (r = 0.8967) (figure 4B). To examine how the frequency of SIV RNA+ cells and the magnitude of immune

activation simultaneously impact the frequency of Treg
cells, we fit a multiple regression model to the data on all
RMs using all variables. The results of this model indicated
that, although the frequency of SIV RNA+ cells was related
to the frequency of Treg cells, when considering the effect of
SIV infection on the frequency of Treg cells given the effect
of immune activation, there was not a statistically significant relationship. However, there was a statistically significant relationship between the magnitude of immune activation and the frequency of Treg cells given the effect of SIV
infection (P = 0006). Therefore, this model indicates that the
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Figure 4. Regulatory T (Treg) cell generation is driven by immune activation in the paracortical T cell zones of lymph nodes during acute simian immunodeficiency virus (SIV) infection of rhesus macaques (RMs). Changes in the frequency of Ki67+ cells mirrored the level of Treg cell expression from 7 to 28 days after intravenous infection (A), and a strong relationship existed between
the frequency of Treg cells and the magnitude of immune activation (B); in contrast, primary rhesus cytomegalovirus (RhCMV)–infected RMs showed a delayed induction of FOXP3+ Treg cells associated with T cell zone immune activation (Ki67+ cells) (C; original magnification, ×400 for FOXP3 and ×100 for Ki67; “TZ” indicates T cell zones, and “GC” indicates germinal centers).

weaker relationship we observed between the frequency of
SIV RNA+ cells and the frequency of Treg cells reflects the
stronger association between the frequency of Treg cells and
the magnitude of immune activation and the relationship
between the magnitude of immune activation and the level
of SIV infection. We think that these data support the hypothesis that viral replication indirectly drives the induction of Treg cells by inducing a massive state of immune
activation.
In contrast, in the RhCMV-infected RMs, immune activation within the paracortical T cell zones was not evident
until 70 days after infection, and the peak Treg cell response
was correspondingly delayed and of lower magnitude (figure 4C). Immune activation in the RhCMV-infected RMs
likely occurred in response to persistent systemic infection
at other anatomic sites, because we did not detect any IE-1+
(immediate early–1 gene product) or pp65+ (matrix phosphoprotein–65 late gene product) productively RhCMV-infected cells in the LN samples by immunohistochemistry

or sensitive polymerase chain reaction techniques (data
not shown). Thus, for both infections, immune activation
is correlated with a counterbalancing Treg cell response,
but the timing is different. Most importantly, the replication- driven immune activation that occurs early during
SIV infection induces a rapid Treg cell response that has the
potential to negatively impact the host cellular immune response to infection while replication continues.
Impact of Treg cells on the CTL response during acute
SIV infection. To test the hypothesis that the early induction of the Treg cell response to counter immune activation and inflammation in SIV-infected lymphatic tissues
might, in fact, detrimentally affect SIV-specific immune responses, we compared the frequency of FOXP3+ Treg cells
to the percentage of SIV-specific CTLs that recognized SL8
(aa 28–35), an immunodominant epitope in Tat that has
been shown to exert strong selective pressure on SIV (figure 5) [19]. We quantified the SL8 tetramer+CD8+ T cell responses in 5 Mamu-A*01 major histocompatibility complex
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Figure 5. Significant inverse correlation between the frequency of FOXP3+ regulatory T (Treg) cells and the magnitude
of the cytotoxic T lymphocyte (CTL) response to the Tat immunodominant epitope SL8. Tetramer analysis was performed
on CTLs that had been isolated from a portion of the obturator
(circles), inguinal (squares), and mesenteric (triangles) lymph
nodes (LNs) from 5 Mamu-A*01 major histocompatibility complex class I allele–positive rhesus macaques (21–28 days after infection). The frequency of Treg cells was determined on
the basis of tissue sections from the same LNs, as described
in Materials and Methods. The relationship was highly significant (P < .01), as determined on the basis of a test of the regression slope in a random effects model, which is described
in detail in Materials and Methods.

class I allele–positive RMs, and we detected significant
percentages (1.25%–4.61%) of SL8 tetramer+ CD8+ T cells
in 2 of them (RM 1919 and RM 27099). In contrast, the SL8
responses were low (0.01%–0.8%) or undetectable in the
other 3 RMs. There was a significant inverse correlation
between the frequency of Treg cells and the percentage of
SL8 tetramer+CD8+ T cells at 21 and 28 days after infection (r = 0.812; P < .01) (figure 5), which is consistent with
the idea that Treg cells inhibit the CTL response to the immunodominant epitope SL8, which has been shown to
play such an important role in the initial partial control of
infection.
Discussion
Shortly after infectious challenges, specific host adaptive
immune responses are initiated to combat these pathological threats. Most pathogens are effectively contained and
then eliminated from the host by these responses; in some
cases, however, the infectious agent is only partially controlled and is not eradicated, resulting in long-term persistent infections, immune hyperactivation, and immunemediated tissue damage [20]. Understanding why the
immune system fails to control these infectious pathogens
is of great interest, particularly for persistent viral infections that result in high morbidity and mortality, such as
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infection with hepatitis C virus and HIV. Here, we provide
evidence that one mechanism for lentiviral persistence may
be a massive immunosuppressive regulatory response induced by the host shortly after viral exposure in secondary
lymphatic tissues in response to corresponding viral replication and immune activation.
There is a growing body of evidence that Treg cells suppress effector immune responses by a variety of mechanisms [8, 9, 15, 20–31]. In addition, it has recently been
shown that Treg cells not only regulate herpes simplex virus–specific CTL responses but may also suppress HIVspecific T cell responses during chronic infection, thus diminishing the magnitude of the immune response to these
viral pathogens [8, 32–38]. Recently, Haeryfar et al. [39]
showed that depleting Treg cells significantly enhanced the
magnitude of the CTL response to influenza A virus–, vaccinia virus–, and simian virus 40–transformed cells in vivo.
These and our present data support a role for Treg cells in
controlling the magnitude of CTL responses in vivo, likely
through inhibiting T cell proliferation and clonal expansion. To add to the growing evidence for control of pathogenic immune responses by Treg cells, we show here for the
first time that, during acute SIV infection, the magnitude
of the SIVspecific CTL response to the Tat immunodominant epitope SL8 is inversely related to the magnitude of
the immunosuppressive Treg cell response. In addition, preliminary results indicate that RMs with high frequencies of
Treg cells in secondary lymphatic tissues have significantly
lower frequencies of both IFN-γ+ cells and IL-12+ cells,
compared with those in RMs with low frequencies of Treg
cells (authors’ unpublished data). Furthermore, the present study indicates that the anatomical distribution of Treg
cells in vivo is primarily contained within the paracortical
T cell zones of secondary lymphatic tissue, the immune inductive site for the stimulation and activation of effector T
cell responses.
Our data suggest that the early, sustained immunosuppressive response is composed, in large part, of TGF-β1+
Treg cells. In the SIV-infected RM model, there are currently
no experimental approaches to show in tissue that the initial Treg cell response is antigen specific, as has been shown
both in vitro and in vivo in other systems [15, 16, 40, 41],
but we reason that the early Treg cell response generated
shortly after SIV exposure is a consequence of immune activation of resident SIV-specific Treg cells in secondary lymphatic tissue. However, it is likely that, by the peak of this
Treg cell response, the production of immunosuppressive
effector cytokines (such as TGF-β1) by antigen-specific Treg
cells may drive the induction of nonspecific inducible “bystander” Treg cells, further amplifying the immunosuppressive response.
What roles TGF-β1 and IL-10 play in the in vivo function of CD4+CD25+ natural Treg cells are still quite controversial. Although most in vitro studies have shown that
CD4+CD25+ Treg cells do not mediate immunosuppression via soluble factors, several in vivo studies have demonstrated the importance of TGFb1 and IL-10 in immunosuppression mediated by CD4+CD25+ Treg cells [42–47].
The present study, which demonstrated the expression of

Premature Induction

of an

I m m u n o s u pp r e s s i v e R e g u l a t o r y T C e l l R e s p o n s e

TGF-β1 and IL-10 by CD4+CD25+FOXP3+ Treg cells, provides further evidence indicating that natural Treg cells
likely use either or both TGF-β1 and IL-10 as mechanisms
for immunosuppression in vivo and shows for the first
time that most natural Treg cells also express the highly immunosuppressive enzyme IDO, which represents another
mechanism for immunosuppression mediated by Treg cells.
The induction of Treg cells during acute SIV infection
likely parallels the induction of immune activation in the
paracortical T cell zones of secondary lymphatic tissue as
a response by the host to control immune-mediated pathological damage due to immune hyperactivation. However, this Treg cell response dose not appear to be capable
of limiting the massive hyperactivation in the lymphatic
compartments during acute SIV infection in RMs. In contrast, a recent study by Kornfeld et al. indicates that, during
the course of natural infection in African green monkeys
(AGMs) infected with SIVagm, a very rapid immunosuppressive response is induced and peaks during the first
week of infection, followed by a decease to baseline levels
[48]. The much more rapid immunosuppressive response
in AGMs abrogates immune hyperactivation, resulting in
a far more benign disease outcome in comparison with that
in RMs. Thus, the timing of the Treg cell response in relation to immune activation and the adaptive immune response is the critical determinant of outcome. The Treg cell
response in SIV-infected RMs is too late to counterbalance
and prevent the immunopathological consequences of sustained immune activation and is too early and untimely
with respect to immune control, as it down-regulates important effector T cell responses before immune control is
achieved. In AGMs, the Treg cell response is also too early
to prevent a persistent infection, with viral replication at
levels comparable with those in SIV-infected RMs, but is
sufficiently early to prevent the immunopathological effects of sustained immune activation.
In summary, we have shown that SIV infection elicits an
early Treg cell response in secondary lymphatic tissue, one
likely driven by the immune activation associated with infection. Although this immunosuppressive response may
limit the immunopathological effects of sustained immune activation and inflammation, the Treg cell response
may also limit SIV-specific immune responses at just the
time when they are critically needed to clear an infection.
We think that a successful vaccine will need to establish a
better balance between these beneficial and adverse effects
of Treg cell responses, and we speculate that there may be
a role for anti-inflammatory treatment during acute infection, to moderate the Treg cell response.
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